-
Study aim
-
Determining the effect of Persian medicine phlebotomy (Fasd) on symptoms of patients with acne vulgaris
-
Design
-
Clinical trial with control group, with factorial groups, randomized, phase 2 on 60 patients. Without blinding, randomization will be done based on stratified patients into two men and women groups and determined blocks of 4 and Table of random numbers
-
Settings and conduct
-
The following steps are done in this study: Determining the severity of acne with the GAGS criteria at the beginning, at the end of months 1, 2, and 3, and measuring the quality of life based on the CADI questionnaire at the beginning and end of the study; Intervention by performing phlebotomy at the beginning and the end of the 2nd month, and taking 150 to 200 cc of blood from cephalic vein at every turn; Both groups receive classic acne treatment. Patients are selected from those who visit the Dermatology or Persian Medicine Clinic of Emam Reza Hospital, and blinding is done only on the analyzer.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: People aged 16 to 25 with moderate to severe acne based on the GAGS index and willing to cooperate in the project
Exclusion criteria: Other skin or systemic diseases, use of medications that can cause acne or anti-acne drugs in the past 3 months, history of allergy to the study drugs, iron deficiency anemia, emaciation, PCOS, general cold temperament, pregnancy or lactation
-
Intervention groups
-
Intervention by performing two rounds of Fasd and removing 150 to 200 cc of blood from the Cephalic vein in each round in addition to classical acne treatment (including 5% topical Benzoyl peroxide daily and 100 mg Doxycycline capsule twice a day orally); Control group receives only conventional acne treatment.
-
Main outcome variables
-
The severity of acne disease, Quality of life